EQUITY RESEARCH MEMO

BioT Medical

Generated 5/25/2026

Executive Summary

Conviction (model self-assessment)68/100

BioT Medical is an Israeli-based cloud infrastructure provider purpose-built for the Internet of Medical Things (IoMT). Founded in 2018, the company offers a secure, compliant, and interoperable platform that enables medical-device manufacturers to deliver connected, data-driven care. BioT’s low-code developer tools and open APIs facilitate rapid integration with electronic health records (EHRs), customer relationship management (CRM) systems, and AI algorithms, reducing time-to-market for next-generation connected devices. The platform spans multiple therapeutic domains including cardiology, neurology, dermatology, and orthotics, positioning BioT as a versatile enabler in the rapidly expanding IoMT ecosystem. The global IoMT market is projected to grow at a CAGR exceeding 20% over the next five years, driven by aging populations, the shift toward remote patient monitoring, and the need for real-time data analytics in clinical decision-making. BioT Medical is well-positioned to capture a share of this growth by offering a specialized, regulatory-compliant cloud layer that addresses key pain points such as data security, interoperability, and scalability. While the company operates in a competitive landscape with larger cloud providers and niche IoMT platforms, its focus on low-code simplicity and domain-specific expertise provides a differentiated value proposition. With a growing customer base and expanding therapeutic coverage, BioT is poised for continued traction, though near-term revenue visibility remains limited given its private-stage status.

Upcoming Catalysts (preview)

  • Q1 2026Strategic partnership with a top-10 medical device manufacturer60% success
  • Q4 2025Achievement of SOC 2 Type II certification85% success
  • Q2 2026Expansion into respiratory monitoring therapeutic area50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)